Trial intelligence / Profile preview

Efficacy of Phenytoin vs Levetiracetam in Pediatric Status Epilepticus

NCT06067412Completed

Sponsor
Shaheed Zulfiqar Ali Bhutto Medical University
Start
Aug 2022
Primary completion
Jan 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of levetiracetam in status epilepticus (SE) (2 arms), sponsored by Shaheed Zulfiqar Ali Bhutto Medical University. Primary endpoint: Efficacy of seizure control at 24 hours. Started Aug 2022; status: completed.

02

Drugs

levetiracetam
03

Conditions

status epilepticus (SE)

Beyond the preview

Go deeper on NCT06067412.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06067412.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call